Search

Your search keyword '"Vita MG"' showing total 56 results

Search Constraints

Start Over You searched for: Author "Vita MG" Remove constraint Author: "Vita MG"
56 results on '"Vita MG"'

Search Results

1. Acromegaly can be cured by first-line pasireotide treatment?

2. The risk stratification of adverse neonatal outcomes in women with gestational diabetes (STRONG) study

3. Cognitive impairment in myotonic dystrophy type 1 (DM1) : A longitudinal follow-up study.

4. Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial

5. Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication.

6. Probable Alzheimer's disease patients presenting as 'focal temporal lobe dysfunction' show a slow rate of cognitive decline

7. Patterns of cognitive decline and rates of conversion to dementia in patients with degenerative and vascular forms of MCI

8. An atypical phenotype of CJD associated with the E200K mutation in the prion protein gene

9. Cognitive impairment in myotonic dystrophy type 1 (DM1): a longitudinal follow-up study

10. Knowledge Sharing Practices and Issues in Policing Contexts. A Systematic Review of the Literature

11. Neuroacanthocytosis Syndromes in an Italian Cohort: Clinical Spectrum, High Genetic Variability and Muscle Involvement

12. Selective impairment of living things and musical instruments on a verbal 'Semantic Knowledge Questionnaire' in a case of apperceptive visual agnosia.

13. An atypical phenotype of CJD associated with the E200K mutation in the prion protein gene

14. Structural and functional alterations of neurons derived from sporadic Alzheimer's disease hiPSCs are associated with downregulation of the LIMK1-cofilin axis.

15. Assessing the efficacy of an innovative diagnostic method for identifying 5 % variants in somatic ctDNA.

16. Different Markers of Semantic-Lexical Impairment Allow One to Obtain Different Information on the Conversion from MCI to AD: A Narrative Review of an Ongoing Research Program.

17. Nucleoporin 153 deficiency in adult neural stem cells defines a pathological protein-network signature and defective neurogenesis in a mouse model of AD.

18. Performance of Fully-Automated High-Throughput Plasma Biomarker Assays for Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subjects.

19. Associations Between Free and Cued Selective Reminding Test and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment.

20. Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia.

21. Neurological Erdheim-Chester Disease Manifesting with Subacute or Progressive Cerebellar Ataxia: Novel Case Series and Review of the Literature.

22. Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1).

23. Neuroacanthocytosis Syndromes in an Italian Cohort: Clinical Spectrum, High Genetic Variability and Muscle Involvement.

24. Subclinical epileptiform activity during sleep in Alzheimer's disease and mild cognitive impairment.

25. Acromegaly can be cured by first-line pasireotide treatment?

26. Predicting progression of amnesic MCI: The integration of episodic memory impairment with perfusion SPECT.

28. Neuroradiology of human prion diseases, diagnosis and differential diagnosis.

29. Patient with rapidly evolving neurological disease with neuropathological lesions of Creutzfeldt-Jakob disease, Lewy body dementia, chronic subcortical vascular encephalopathy and meningothelial meningioma.

30. Standardization, Clinical Validation, and Typicality Norms of a New Test Assessing Semantic Verbal Fluency.

31. Are Raw Scores on Memory Tests Better than Age- and Education- Adjusted Scores for Predicting Progression from Amnesic Mild Cognitive Impairment to Alzheimer Disease ?

32. Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication.

33. Cognitive and behavioral determinants of psychotic symptoms in Alzheimer's disease.

34. Does semantic memory impairment in amnestic MCI with hippocampal atrophy conform to a distinctive pattern of progression?

35. Typicality of words produced on a semantic fluency task in amnesic mild cognitive impairment: linguistic analysis and risk of conversion to dementia.

36. Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease.

37. Human brain networks in cognitive decline: a graph theoretical analysis of cortical connectivity from EEG data.

38. Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma.

39. R208H-129VV haplotype in the prion protein gene: phenotype and neuroimaging of a patient with genetic Creutzfeldt-Jakob disease.

40. Selective impairment of action-verb naming and comprehension in progressive supranuclear palsy.

41. Links between metabolic syndrome and cardiovascular autonomic dysfunction.

42. Probable Alzheimer's disease patients presenting as "focal temporal lobe dysfunction" show a slow rate of cognitive decline.

43. Patterns of cognitive decline and rates of conversion to dementia in patients with degenerative and vascular forms of MCI.

44. An atypical phenotype of CJD associated with the E200K mutation in the prion protein gene.

45. Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment.

46. Psychotic symptoms in Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: evidence for an association.

47. Visual hallucinations and pontine demyelination in a child: possible REM dissociation?

48. Cognitive impairment in myotonic dystrophy type 1 (DM1): a longitudinal follow-up study.

49. Patterns of neuropsychological impairment in MCI patients with small subcortical infarcts or hippocampal atrophy.

50. Serological testing for celiac disease in women undergoing assisted reproduction techniques.

Catalog

Books, media, physical & digital resources